Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...

Abbott acquired the pharmaceutical business of BASF, including the global operations of Knoll Pharmaceuticals, expanding the company's global scope and ... for recurrent bladder cancer was approved.

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating ...

Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.

Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering ...

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring.

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Discover a recent study that introduced a novel approach combining preoperative 3D printing with intraoperative ...

The prevalence of UI range increases with age from 17–55% in older women. Overactive bladder (OAB) syndrome is defined as urinary urgency, with or without urinary incontinence, usually with ...

Former England rugby international Maggie Alphonsi has said women's sport cannot allow itself to stop growing after a period of accelerated progress in recent years. Alphonsi was in Dublin on ...

The best loafers for women are comfortable, stylish and versatile, and they should take you from day to night with ease. Whether you’re looking for a timeless penny loafer or modern lug sole ...